Ferroptosis in Cognitive Impairment Associated with Diabetes and Alzheimer's Disease: Mechanistic Insights and New Therapeutic Opportunities

被引:2
|
作者
Ma, Mei [1 ]
Jing, Guangchan [1 ]
Tian, Yue [1 ]
Yin, Ruiying [1 ]
Zhang, Mengren [1 ]
机构
[1] Peking Union Med Coll & Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Tradit Chinese Med, Beijing 100730, Peoples R China
关键词
Ferroptosis; Cognitive impairment; Alzheimer's disease; Diabetes; Natural products; BRAIN IRON DEPOSITION; INSULIN-RESISTANCE; PC12; CELLS; IN-VIVO; ACCUMULATION; PEROXIDATION; DYSFUNCTION; EXPRESSION; APOPTOSIS; PROTECTS;
D O I
10.1007/s12035-024-04417-9
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Cognitive impairment associated with diabetes and Alzheimer's disease has become a major health issue affecting older individuals, with morbidity rates growing acutely each year. Ferroptosis is a novel form of cell death that is triggered by iron-dependent lipid peroxidation. A growing body of evidence suggests a strong correlation between the progression of cognitive impairment and diabetes, Alzheimer's disease, and ferroptosis. The pharmacological modulation of ferroptosis could be a promising therapeutic intervention for cognitive impairment associated with diabetes and Alzheimer's disease. In this review, we summarize evidence on ferroptosis in the context of cognitive impairment associated with diabetes and Alzheimer's disease and provide detailed insights into the function and potential action pathways of ferroptosis. Furthermore, we discuss the therapeutic importance of natural ferroptosis products in improving the cognitive impairment associated with diabetes and Alzheimer's disease and provide new insights for clinical treatment.
引用
收藏
页码:2435 / 2449
页数:15
相关论文
共 50 条
  • [21] Nutraceuticals in cognitive impairment and Alzheimer's disease
    Mecocci, P.
    Tinarelli, C.
    Schulz, R. J.
    Polidori, M. C.
    FRONTIERS IN PHARMACOLOGY, 2014, 5
  • [22] Mechanistic Insights and Emerging Therapeutic Targets of Alzheimer's Disease: From the Perspective of Inter-Organ Crosstalk
    Yin, Jianqiong
    Peng, Wei
    Lu, Lu
    Hong, Zhen
    Zhou, Dong
    Li, Jinmei
    AGING AND DISEASE, 2025,
  • [23] Regulation of Diabetes: a Therapeutic Strategy for Alzheimer's Disease?
    Ahn, Kee-Chan
    Learman, Cameron R.
    Baker, Glen B.
    Weaver, Charles L.
    Chung, Phil-Sang
    Kim, Hyung Gun
    Song, Mee-Sook
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2019, 34 (46)
  • [24] New strategies for Alzheimer disease and cognitive impairment
    Maiese, Kenneth
    Chong, Zhao Zhong
    Hou, Jinling
    Shang, Yan Chen
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2009, 2 (05) : 279 - 289
  • [25] Iron Dyshomeostasis and Ferroptosis: A New Alzheimer's Disease Hypothesis?
    Wang, Feixue
    Wang, Jiandong
    Shen, Ying
    Li, Hao
    Rausch, Wolf-Dieter
    Huang, Xiaobo
    FRONTIERS IN AGING NEUROSCIENCE, 2022, 14
  • [26] Long-term central pathology and cognitive impairment are exacerbated in a mixed model of Alzheimer's disease and type 2 diabetes
    Infante-Garcia, Carmen
    Jose Ramos-Rodriguez, Juan
    Galindo-Gonzalez, Lucia
    Garcia-Alloza, Monica
    PSYCHONEUROENDOCRINOLOGY, 2016, 65 : 15 - 25
  • [27] Ferroptosis and myocardial ischemia-reperfusion: mechanistic insights and new therapeutic perspectives
    Jin, Binwei
    Zhang, Zhiming
    Zhang, Yang
    Yang, Minjun
    Wang, Cheng
    Xu, Jiayi
    Zhu, Yu
    Mi, Yafei
    Jiang, Jianjun
    Sun, Zhenzhu
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [28] Therapeutic Efficacy of Plasmalogens for Alzheimer's Disease, Mild Cognitive Impairment, and Parkinson's Disease in Conjunction with a New Hypothesis for the Etiology of Alzheimer's Disease
    Fujino, Takehiko
    Hossain, Md Shamim
    Mawatari, Shiro
    PEROXISOME BIOLOGY: EXPERIMENTAL MODELS, PEROXISOMAL DISORDERS AND NEUROLOGICAL DISEASES, 2020, 1299 : 195 - 212
  • [29] Ghrelin Induces Ferroptosis Resistance and M2 Polarization of Microglia to Alleviate Neuroinflammation and Cognitive Impairment in Alzheimer's Disease
    Guo, Yaoxue
    Zhao, Junli
    Liu, Xing
    Lu, Pu
    Liang, Furu
    Wang, Xueyan
    Wu, Jing
    Hai, Yan
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2025, 20 (01)
  • [30] Sennoside A restrains TRAF6 level to modulate ferroptosis, inflammation and cognitive impairment in aging mice with Alzheimer's Disease
    Li, Xiaojia
    Wang, Xiaoping
    Huang, Bin
    Huang, Rui
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 120